Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection.

Krpina, Kristina; Mavrinac, Martina; Samarzija, Miroslav; Tolic, Ena; Darapi, Dora; Baticic, Lara

Krpina, Kristina; Mavrinac, Martina; Samarzija, Miroslav; Tolic, Ena; Darapi, Dora; Baticic, Lara.

Afiliação

Krpina K; Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Mavrinac M; Department of Medical Informatics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Samarzija M; Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Tolic E; Faculty of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Darapi D; Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Baticic L; Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.

J Clin Med ; 11(22)2022 Nov 11.

Article em En | MEDLINE | ID: mdl-36431171

Palavras-chave

COVID-19; chemotherapy; immunotherapy; lung immune prognostic index; non-small-cell lung cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Croácia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google